Kratom & kava guides
What Are MIT Tablets? Strength, Flavor & Lab Results
Mango MIT Tablets contain 150mg of mitragynine in a compact, firm chewable.
The light mango flavor softens the concentrate's pronounced bitterness, while the firm, dry texture distinguishes the tablet from a soft gummy or plain kratom leaf.
What “MIT tablet” means
MIT is shorthand for mitragynine, the principal psychoactive alkaloid usually measured in Mitragyna speciosa leaf. An MIT tablet is a formulated extract product containing a specific amount of mitragynine. Leaf capsules, 7-hydroxymitragynine, MGPI, MGM-15, and MGM-16 each have their own material or compound identities.
No loose powder or liquid bottle
Skip the scale, mixing and loose-powder mess. There is no liquid bottle to open or reseal, so you avoid carrying a drink container as well.
How tablets differ from other kratom products
- Leaf capsules contain dried kratom leaf inside a shell and carry a leaf-fill weight.
- Kratom gummies contain concentrated extract in a soft, sweet fruit chew. Their formula also contains acids and gelling ingredients and is more sensitive to heat than a dry tablet.
- Liquid shots carry concentrated alkaloids in a small bottle and may use per-serving or per-bottle declarations alongside fluid volume.
- MIT extract powder is an unflavored loose concentrate that you measure yourself.
The Kratom Extract Types & Formats Guide examines those categories in more detail.
Lab tested at 146mg per tablet
Lot M/150/002 lab tested at 146mg mitragynine, 0.148mg 7-hydroxymitragynine, and 153mg total Mitragyna alkaloids per tablet. Match the COA to the lot on your package.
MIT, 7-OH, and MGM-15 are distinct compounds
Mitragynine and 7-OH are related but distinct compounds. 7-OH has stronger mu-opioid-receptor activity, and enriched products can deliver far more 7-OH than ordinary leaf. DEA's August 26, 2026 temporary Schedule I order names MGM-15, MGPI, and MGM-16; mitragynine retains its separate federal status.
For the current distinctions, read 7-OH vs Kratom vs MIT and the DEA scheduling tracker.
Effects and safety
Mitragynine acts at human opioid receptors and can produce alerting or relaxing effects. Concentrated products can also cause nausea, dizziness, constipation, sedation, tolerance, dependence, withdrawal, and interactions. Chemistry, amount, use pattern, medications, other substances, and individual physiology shape the response.
Shop MIT Chewable Tablets or bulk packs, or compare both formats in the MIT Products Guide.